|
Mr. Bagley is President and Chief Operating Officer and a Director and has served in this capacity since July 2004. Additionally Mr. Bagley has been Chief Financial Officer and Treasurer since March 2005. Mr. Bagley initiated a career in pharmaceuticals in 1968 with Smith Kline and French Laboratories leaving in 1985 after launching Tagamet in the U.S. as Vice President for Pharmaceutical Product Management and serving as President in the over-the-counter/consumer group. From 1985-1990 Mr. Bagley served in several capacities at Squibb Corporation including as President of E. R. Squibb & Sons U.S. in 1988 and 1989. He subsequently worked in the biotechnology industry as Director Chief Executive Officer and President of ImmuLogic Pharmaceutical Corporation from 1990 to 1994 as Director Chief Executive Officer and Chairman of ProScript Inc. from 1994 to 1998 as Director President and Chief Executive Officer of AltaRex Corp. from 1998 to May 2003 and thereafter as a part time consultant and senior advisor. | 